Resources   sector

Pharmaceuticals

Creating value for all: Strategies for doing business with the poor

The Growing Inclusive Markets Initiative responds to a need for better understanding of how the private sector can contribute to human development and to the Millennium Development Goals. Led by UNDP, the initiative was conceived in 2006 after the success of Unleashing Entrepreneurship: Making Business Work for the Poor—the 2004 ...

> Read more

The next four billion: market size and business strategy at the base of the pyramid

Four billion low-income consumers, a majority of the world’s population, constitute the base of the economic pyramid. New empirical measures of their aggregate purchasing power and their behavior as consumers suggest significant opportunities for market-based approaches to better meet their needs, increase their productivity and incomes, and empower their entry ...

> Read more

Global marketing of lifesaving drugs: an analogical model

In light of the desire to bring about an increase in the global distribution of lifesaving drugs at affordable prices, the purpose of this paper is to focus on the global marketing of lifesaving drugs related to the current pandemic of HIV/AIDS. An analogical model is used to challenge companies ...

> Read more

The Slow Race: Making technology work for the poor

Citizen engagement is vital to ensure that science and technology respond to the challenges of international development. ...

> Read more

Bioexpectations: Life technologies as humanitarian goods

Expectations that people should live—even under extreme conditions of crisis, neglect, and poverty—now combine with doubts about the capacity of states to provide for their populations. One result has been a set of technologies built around minimalist forms of care. Created by a heterogeneous movement of corporations as well as ...

> Read more

Oxymoron no more: The potential of nonprofit drug companies to deliver on the promise of medicines for the developing world

Although some pharmaceutical company efforts to develop and distribute drugs in developing countries have been successful, many fall short of meeting needs in resource-poor nations. In the context of public-private partnerships, we discuss the concept of a nonprofit pharmaceutical company dedicated to developing and distributing drugs for diseases endemic in ...

> Read more